These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 29199977)

  • 21. Nucleotide binding and GTP hydrolysis by the 21-kDa product of the c-H-ras gene as monitored by proton-NMR spectroscopy.
    Löw A; Sprinzl M; Limmer S
    Eur J Biochem; 1993 Apr; 213(2):781-8. PubMed ID: 8386636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural basis for the unique biological function of small GTPase RHEB.
    Yu Y; Li S; Xu X; Li Y; Guan K; Arnold E; Ding J
    J Biol Chem; 2005 Apr; 280(17):17093-100. PubMed ID: 15728574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ab initio study of the role of lysine 16 for the molecular switching mechanism of Ras protein p21.
    Futatsugi N; Hata M; Hoshino T; Tsuda M
    Biophys J; 1999 Dec; 77(6):3287-92. PubMed ID: 10585950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal structures at 2.2 A resolution of the catalytic domains of normal ras protein and an oncogenic mutant complexed with GDP.
    Tong LA; de Vos AM; Milburn MV; Kim SH
    J Mol Biol; 1991 Feb; 217(3):503-16. PubMed ID: 1899707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High frequency (139.5 GHz) electron paramagnetic resonance characterization of Mn(II)-H2(17)O interactions in GDP and GTP forms of p21 ras.
    Bellew BF; Halkides CJ; Gerfen GJ; Griffin RG; Singel DJ
    Biochemistry; 1996 Sep; 35(37):12186-93. PubMed ID: 8810926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mapping the nucleotide-dependent conformational change of human N-ras p21 in solution by heteronuclear-edited proton-observed NMR methods.
    Hu JS; Redfield AG
    Biochemistry; 1993 Jul; 32(26):6763-72. PubMed ID: 8329399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regional polysterism in the GTP-bound form of the human c-Ha-Ras protein.
    Ito Y; Yamasaki K; Iwahara J; Terada T; Kamiya A; Shirouzu M; Muto Y; Kawai G; Yokoyama S; Laue ED; Wälchli M; Shibata T; Nishimura S; Miyazawa T
    Biochemistry; 1997 Jul; 36(30):9109-19. PubMed ID: 9230043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ras-catalyzed hydrolysis of GTP: a new perspective from model studies.
    Maegley KA; Admiraal SJ; Herschlag D
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8160-6. PubMed ID: 8710841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GTP Binding and Oncogenic Mutations May Attenuate Hypervariable Region (HVR)-Catalytic Domain Interactions in Small GTPase K-Ras4B, Exposing the Effector Binding Site.
    Lu S; Banerjee A; Jang H; Zhang J; Gaponenko V; Nussinov R
    J Biol Chem; 2015 Nov; 290(48):28887-900. PubMed ID: 26453300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structures of active conformations of Gi alpha 1 and the mechanism of GTP hydrolysis.
    Coleman DE; Berghuis AM; Lee E; Linder ME; Gilman AG; Sprang SR
    Science; 1994 Sep; 265(5177):1405-12. PubMed ID: 8073283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystal structure of human RhoA in a dominantly active form complexed with a GTP analogue.
    Ihara K; Muraguchi S; Kato M; Shimizu T; Shirakawa M; Kuroda S; Kaibuchi K; Hakoshima T
    J Biol Chem; 1998 Apr; 273(16):9656-66. PubMed ID: 9545299
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calculation of pathways for the conformational transition between the GTP- and GDP-bound states of the Ha-ras-p21 protein: calculations with explicit solvent simulations and comparison with calculations in vacuum.
    Diaz JF; Wroblowski B; Schlitter J; Engelborghs Y
    Proteins; 1997 Jul; 28(3):434-51. PubMed ID: 9223188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal structures of the state 1 conformations of the GTP-bound H-Ras protein and its oncogenic G12V and Q61L mutants.
    Muraoka S; Shima F; Araki M; Inoue T; Yoshimoto A; Ijiri Y; Seki N; Tamura A; Kumasaka T; Yamamoto M; Kataoka T
    FEBS Lett; 2012 Jun; 586(12):1715-8. PubMed ID: 22584058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissection of the GTPase mechanism of Ras protein by MD analysis of Ras mutants.
    Friedman ZY; Devary Y
    Proteins; 2005 May; 59(3):528-33. PubMed ID: 15789417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rap1A antagonizes the ability of Ras and Ras-Gap to inhibit muscarinic K+ channels.
    Yatani A; Quilliam LA; Brown AM; Bokoch GM
    J Biol Chem; 1991 Nov; 266(33):22222-6. PubMed ID: 1939245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Millisecond Allosteric Dynamics of Activated Ras Reproduced with a Slowly Hydrolyzable GTP Analogue.
    Chen X; Gao H; Long D
    Chembiochem; 2021 Mar; 22(6):1079-1083. PubMed ID: 33140496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conformation change of effector-region residues in antiparallel beta-sheet of human c-Ha-ras protein on GDP----GTP gamma S exchange: a two-dimensional NMR study.
    Yamasaki K; Kawai G; Ito Y; Muto Y; Fujita J; Miyazawa T; Nishimura S; Yokoyama S
    Biochem Biophys Res Commun; 1989 Aug; 162(3):1054-62. PubMed ID: 2669742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The mechanism of Ras GTPase activation by neurofibromin.
    Phillips RA; Hunter JL; Eccleston JF; Webb MR
    Biochemistry; 2003 Apr; 42(13):3956-65. PubMed ID: 12667087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electrostatic control of GTP and GDP binding in the oncoprotein p21ras.
    Muegge I; Schweins T; Langen R; Warshel A
    Structure; 1996 Apr; 4(4):475-89. PubMed ID: 8740369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Time-resolved X-ray crystallographic study of the conformational change in Ha-Ras p21 protein on GTP hydrolysis.
    Schlichting I; Almo SC; Rapp G; Wilson K; Petratos K; Lentfer A; Wittinghofer A; Kabsch W; Pai EF; Petsko GA
    Nature; 1990 May; 345(6273):309-15. PubMed ID: 2111463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.